Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders by 김연정 et al.
ORIGINAL RESEARCHRegulation of CFTR Bicarbonate Channel Activity by WNK1:
Implications for Pancreatitis and CFTR-Related Disorders
Yonjung Kim,1,* Ikhyun Jun,1,2,* Dong Hoon Shin,1 Jihoon G. Yoon,1 He Piao,1 Jinsei Jung,1,3
Hyun Woo Park,4 Mary Hongying Cheng,5 Ivet Bahar,5 David C. Whitcomb,6 and Min Goo Lee1
1Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Severance Biomedical Science Institute,
Yonsei University College of Medicine, Seoul, Korea; 2Institute of Vision Research, Department of Ophthalmology, Yonsei
University College of Medicine, Seoul, Korea; 3Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul,
Korea; 4Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea; 5Department of
Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; and 6Division of Gastroenterology,
Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, PennsylvaniaSUMMARY
This study demonstrates that the N-terminal region of with-no-
lysine kinase 1 increases the bicarbonate permeability and
conductance of cystic fibrosis transmembrane conductance
regulator anion channels via an intracellular chloride
concentration–dependent physical association, which facilitates
transepithelial bicarbonate secretion. Defects in this process
underlie the pathogenesis of some cystic fibrosis trans-
membrane conductance regulator–related disorders.
BACKGRAOUD & AIMS: Aberrant epithelial bicarbonate (HCO3
)
secretion caused by mutations in the cystic fibrosis trans-
membrane conductance regulator (CFTR) gene is associated with
several diseases including cystic fibrosis and pancreatitis.
Dynamically regulated ion channel activity and anion selectivity of
CFTR by kinases sensitive to intracellular chloride concentration
([Cl]i) play an important role in epithelial HCO3
 secretion.
However, the molecular mechanisms of how [Cl]i-dependent
mechanisms regulate CFTR are unknown.
METHODS: We examined the mechanisms of the CFTR HCO3

channel regulation by [Cl]i-sensitive kinases using an integrated
electrophysiological, molecular, and computational approachincluding whole-cell, outside-out, and inside-out patch clamp re-
cordings and molecular dissection of WNK1 and CFTR proteins. In
addition, we analyzed the effects of pancreatitis-causing CFTR
mutations on the WNK1-mediated regulation of CFTR.
RESULTS: Among the WNK1, SPAK, and OSR1 kinases that
constitute a [Cl]i-sensitive kinase cascade, the expression ofWNK1
alone was sufficient to increase the CFTR bicarbonate permeability
(PHCO3/PCl) and conductance (GHCO3) in patch clamp recordings.
Molecular dissection of theWNK1domains revealed that theWNK1
kinase domain is responsible for CFTR PHCO3/PCl regulation by
direct association with CFTR, while the surrounding N-terminal
regions mediate the [Cl]i-sensitivity of WNK1. Furthermore, the
pancreatitis-causing R74Q andR75Qmutations in the elbowhelix 1
of CFTR hamperedWNK1-CFTR physical associations and reduced
WNK1-mediated CFTR PHCO3/PCl regulation.
CONCLUSION: The CFTR HCO3
 channel activity is regulated
by [Cl]i and a WNK1-dependent mechanism. Our results
provide new insights into the regulation of the ion selectivity of
CFTR and the pathogenesis of CFTR-related disorders. (Cell Mol
Gastroenterol Hepatol 2020;9:79–103; https://doi.org/10.1016/
j.jcmgh.2019.09.003)
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gastrointestinal, respiratory, and genitourinary systems and
sweat glands secrete and absorb bicarbonate (HCO3
)-
containing fluids.1–3 HCO3
 is an essential ingredient in
these fluids and performs a wide range of functions. For
example, HCO3
 in the pancreatic juice maintains zymogens
in inactive forms within the pancreas, neutralizes gastric
acid in the duodenum, and provides an optimum pH envi-
ronment for digestive enzyme activity in the intestinal
lumen.4 Moreover, aberrant epithelial HCO3
 secretion may
cause mucin aggregation and mucus plug formation,5 which
has been hypothesized to underlie the pathogenesis of cystic
fibrosis and certain forms of pancreatitis.2,6
In humans, postprandial pancreatic juice contains >140-
mMHCO3
, indicating that almost all of the anions in the juice
are HCO3
.7 How human pancreatic duct cells secrete fluids
that contain such a high HCO3
 content has long been a
puzzle. The identification of critical transporters and their
regulatory mechanisms during the last 2 decades has
revealed basic principles of pancreatic HCO3
 secretion. For
example, coordination of basolateral HCO3
 uptake and api-
cal HCO3
 exit mechanisms by IRBIT plays an important role
in agonist-stimulated HCO3
 secretion in pancreatic ducts.8,9
Anion exchangers in the apical membrane of pancreatic duct
cells (presumably SLC26A6 and SLC26A3) appear to mediate
the apical exit of HCO3
 during the initial phase of stimulated
pancreatic secretion10; however, as the luminal HCO3
 con-
centration increases, HCO3
 channel activity at the apical
membrane is required to maintain the continuous secretion
of HCO3
 and fluids.11 According to the Nernst equation, duct
cells can secrete HCO3
-rich fluids until the luminal HCO3

concentration reaches 200 mM, when the duct cells retain a
–60-mV apical membrane potential.12
Evidence suggests that CFTR mediates HCO3
 channel
activity at the apical membrane of pancreatic duct cells.13,14
The CFTR gene was first identified as a gene associated with
cystic fibrosis.15 CFTR has anion channel activity that con-
ducts anions passively down an electrochemical gradient.
Cl and HCO3
 are the most abundant anions in the intra-
cellular and extracellular fluids of animals. Similar to other
mammalian anion channels, Cl permeates the CFTR chan-
nel more readily than HCO3
 under normal conditions and
has a relative HCO3
 permeability (PHCO3/PCl) of
0.2–0.4.16,17 The CFTR PHCO3/PCl is not fixed, however, and
can be dynamically modulated by cellular stimuli. For
example, a low-[Cl]i stimulus can increase the CFTR PHCO3/
PCl to >1 via the activation of [Cl
]i-sensitive kinases.
14
Modeling studies predict that high permeability (PHCO3)
and conductance (GHCO3) of bicarbonate via CFTR is essen-
tial for generating high bicarbonate flux across duct cells to
sustain robust bicarbonate secretion.11,18
Several ion channels and transporters, particularly those
transporting Cl, are regulated by [Cl]i-sensitive kinases
such as the with-no-lysine kinases (WNKs) and the sterile
20 (STE20)-like kinases. In general, it is believed that
WNKs, including WNK1, are initially activated by osmotic
stresses, in particular by a decrease in [Cl]i, andsubsequently phosphorylate and activate downstream
STE20-like kinases, including oxidative stress-responsive ki-
nase 1 (OSR1) and STE20/SPS1-related proline/alanine-rich
kinase (SPAK).19 Then, the activated STE20-like kinases
modulate the activity and cell-surface expression of mem-
brane transport proteins such as the Naþ-Cl cotransporters
and the Naþ-Kþ-Cl cotransporters (NKCCs).20,21 In the
pancreas, the [Cl]i isw20 mM in resting ducts cells and falls
to w5 mM during stimulated pancreatic secretion.11–13,22 It
has been shown that increase in the CFTR PHCO3/PCl by [Cl
]i-
sensitive kinases is essential for pancreatic HCO3
 secretion.14
WNK1 does not affect the PHCO3/PCl of the calcium-activated
anion channel TMEM16A/ANO1,23 which implies that
WNK1-mediated PHCO3/PCl anion channel modulation is not a
generalized phenomenon and is potentially specific to CFTR.
Notably, defects in CFTR-mediated HCO3
 channel activity
were shown to be associated with pancreatitis and other
epithelial disorders.6,24 However, the molecular mechanisms
by which [Cl]i-sensitive kinases regulate CFTR anion selec-
tivity and certain CFTR variants increase the risk of epithelial
disorders are unknown. Here, we show that physical associ-
ations between the N-terminal region of WNK1 and CFTR
mediate the [Cl]i-sensitive regulation of CFTR HCO3

permeability and conductance. We also demonstrate that de-
fects in this process underlie the pathogenesis of some CFTR-
related disorders by showing that the pancreatitis-causing
CFTR mutations R74Q and R75Q6 in the elbow helix region
hamper the WNK1-CFTR physical association and reduce the
WNK1-mediated regulation of CFTR HCO3
 channel activity.Results
WNK1 Alone Is Sufficient for the Regulation of
CFTR HCO3
 Permeability and Conductance
We previously showed that activation of the WNK1-
SPAK/OSR1 pathway increases the PHCO3/PCl of CFTR,
which may play a role in pancreatic HCO3
 secretion.14 To
identify the determinant of WNK1-SPAK/OSR1 signaling, we
first examined the effects of single and combinatorial ex-
pressions of these kinases on CFTR PHCO3/PCl. The relative
anion permeability was measured using whole-cell
recording of human CFTR expressed in HEK293T cells
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To activate the WNK1-SPAK/OSR1 pathway, the pipette
solution contained a low concentration of Cl (10 mM). As
shown in Figure 1A–D, cAMP stimulation of CFTR-
expressing HEK293T cells evoked an anion current, which
induced a negative shift in the membrane potential due to
the influx of Cl. Notably, current reductions of up to 80%
did not greatly affect membrane potentials. The conduc-
tance levels of background currents (GBG) were 0.2–0.5 nS
and those of cAMP-activated CFTR currents (GCFTR) were
10–30 nS. Inhibition of CFTR currents by 83% with the
CFTR inhibitor, CFTRinh-172 (10 mM), increased the ratio of
the background currents to the CFTR currents (GBG/GCFTR)
from approximately 0.02 to 0.10, which caused a subtle
change in membrane potential (<5 mV, corresponding to
<0.1 in PHCO3/PCl) (Figure 1E and F). These data indicated
that background or leak currents did not significantly affect
the results in membrane potential measurements (see also
Discussion).
In Figure 1G, the replacement of bath solutions with a
HCO3
-rich solution evoked membrane depolarization,
indicating that CFTR PHCO3 is smaller than PCl, and an
average of 41% reduction in anion conductance, indicating
that CFTR GHCO3 is smaller than GCl under control condi-
tions. During a 6-minute whole-cell recording, the mem-
brane potential was not altered by a partial rundown (up to
17%) of the anion conductance (Figure 1G–I).
Representative whole-cell recording with coexpression
of WNK1, SPAK, and OSR1 are shown in Figure 2A–H (zero-
current clamp) and Figure 3 (current-voltage [I-V] rela-
tionship). A summary of the PHCO3/PCl values from the
zero-current clamp recordings is presented in Figure 2I. As
reported previously,14 CFTR PHCO3/PCl is significantly
increased by WNK1-SPAK or WNK-OSR1 under the low-
[Cl]i condition (Figures 2A–C and 3A–C). In contrast to the
known regulation of Naþ-Cl cotransporters or NKCC that
requires downstream STE20-like kinases (SPAK or
OSR1),19,20 the expression of WNK1 alone increased CFTR
PHCO3/PCl under low-[Cl
]i conditions (Figures 2D and 3D).
Furthermore, expression of SPAK and OSR1 did not affectFigure 1. (See previous page). Measurements of CFTR Cl L
cAMP-activated Cl current was measured in HEK293T cells tran
Representative voltage and current measurements are shown in
presented in panels B and D). The pipette and bath solutions
currents were activated by cAMP (5-mM forskolin and 100-mM
determine the I-V relationship during zero-current clamp recordi
and an I-V curve was obtained by applying ramp pulses. Arrows
stimulation evoked no discernible voltage and current change
treatment evoked a Cl current in CFTR-expressing cells, whic
influx Cl (n ¼ 9). (E, F) The cAMP-activated CFTR current wa
inhibitor, CFTRinh-172. Two examples of sample traces, showing
change by CFTRinh-172, are shown in panel E. A summary of vol
F. (G, H) CFTR currents were activated by 5-mM forskolin and 10
Cl. The initial bath solution containing 150-mM Cl was replac
Replacing bath solutions with a HCO3

–rich solution (G) evok
conductance of CFTR. (I) A summary of slope conductance data
solution evoked a 41% reduction in anion conductance (G2/G1
83% of CFTR Cl conductance (G4/G1) and membrane potential
are presented as the mean ± SEM.CFTR PHCO3/PCl. (Figures 2E–G and 3E–G; a summary in
Figure 2H). The WNK1 effect occurred in cells in which
endogenous SPAK and OSR1 were silenced, further indi-
cating that SPAK and OSR1 are not required for CFTR
regulation and that WNK1 alone is sufficient for upregula-
tion of CFTR PHCO3/PCl (Figures 2H and 3H). The immuno-
blot results shown in Figure 2J verified the proper
expression and silencing of SPAK and OSR1 in the experi-
ments. Of interest, WNK1 increased not only HCO3

permeability, but also HCO3
 conductance (GHCO3) of CFTR
(Figure 4). The surface biotinylation data indicated that
neither depletion nor overexpression of WNK1 significantly
altered the cell-surface expression of CFTR in HEK293T cells
(Figure 5). These results suggest that WNK1 regulates CFTR
HCO3
 permeability and conductance by modulating the
anion channel properties rather than altering CFTR stability
or trafficking.WNK1 N-Terminal Region Is Critical for the
Upregulation of CFTR PHCO3/PCl
We next examined the effects of WNK1 on CFTR using
truncated WNK1 proteins to identify the critical domains that
regulate CFTR PHCO3/PCl (Figures 6 and 7). WNK1 is a large
protein composed of 2126 amino acids (Figure 8A).25 Plas-
mids expressing the N-terminal proline-rich domain (PRD)
[WNK1(1–119)], PRD þ N-linker (NL) [WNK1(1–221)], ki-
nase domain [WNK1(221–491)], PRD þ NL þ kinase domain
[WNK1(1–491)], or the remaining C-terminal regions
[WNK1(492–2126)] were co-transfected in HEK293T cells,
and CFTR PHCO3/PCl was analyzed by measuring whole-cell
current. Figures 6A–G and 7 show representative zero-
current clamp recording and I-V measurements, respec-
tively. Figure 6H shows a summary of the PHCO3/PCl values
from zero-current clamp recordings. The expression of the
WNK1 N-terminal regions [WNK1(1–491)] (Figures 6F and
7F), and particularly that of the kinase domain
[WNK1(221–491)] alone (Figure 6E and 7E), increased the
CFTR PHCO3/PCl, whereas that of the remaining C-terminal
regions [WNK1(492–2126)] did not (Figure 6G and 7G).and HCO3
L channel activities in control cells. (A–D) The
sfected with (A, B) mock or (C, D) CFTR-expressing plasmids.
panels A and C) and a summary of voltage measurements is
contained 10-mM Cl and 150-mM Cl, respectively. CFTR
IBMX) after whole-cell configuration was established. To
ngs, the clamp mode was shifted to the voltage clamp mode,
indicate the time point to measure I-V curve. (A, B) The cAMP
s in mock transfected cells (n ¼ 6). (C, D) The same cAMP
h induced a negative shift of membrane potential due to the
s measured in HEK293T cells after treatment with the CFTR
the minimum (Example 1) and maximum (Example 2) voltage
tage and current change by CFTRinh-172 is presented in panel
0-mM IBMX. The pipette and bath solutions contained 10-mM
ed with a solution containing 146-mM HCO3
 and 4-mM Cl.
ed a membrane depolarization and (H) reductions in anion
is shown (n ¼ 7). Replacing bath solutions with a HCO3–rich
). During a 6-minute whole-cell recording, cells retained over
s were not altered [compare points (1) and (4) in panel G). Data
Figure 2. WNK1 alone is sufficient to regulate CFTR HCO3
L permeability. (A–I) The relative HCO3
 permeability (PHCO3/PCl
of CFTR was analyzed using HEK293T cells transfected with plasmids expressing CFTR, Myc-WNK1, Flag-OSR1, Flag-SPAK
or siRNAs against SPAK and OSR1. Whole-cell currents were measured after the activation of CFTR channels by cAMP (5-mM
forskolin and 100-mM IBMX). The initial bath solution containing 150-mM Cl was replaced with a solution containing 4-mM
Cl and 146-mM HCO3
. Representative voltage measurements are shown in A-H, and a summary of PHCO3/PCl values from
the zero-current clamp recording is presented in panel I. To determine the current-voltage (I-V) relationship during zero-curren
clamp recordings, the clamp mode was shifted to the voltage clamp mode, and an I-V relationship was obtained by applying
ramp pulses (Figure 3, arrows indicate the time points that were used to measure the I-V relationship). Bar-graph data are
presented as the mean ± SEM. *P < .05, **P < .01: difference from CFTR alone. (J) Expression of CFTR, WNK1, OSR1, and
SPAK was analyzed by immunoblotting. HEK293T cells transiently transfected with plasmids containing CFTR, Myc-WNK1
Flag-SPAK, and Flag-OSR expressed proteins with the appropriate molecular weights (left panel). siRNAs against SPAK
and OSR1 abolished endogenous expression of SPAK and OSR1 (right panel). The b-actin blot represents the housekeeping
loading control. Four independent experiments displayed similar results.
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Figure 3. I-V relationship for the whole-cell current measurements in Figure 2A–H. (A-H) The I-V relationship was
measured at each time point marked in the corresponding panels of Figure 2A-H. The I-V relationship was measured at each
time point marked in the corresponding panels of Figure 2A-H. The PHCO3/PCl of CFTR was analyzed using HEK293T cells
transfected with plasmids expressing CFTR, Myc-WNK1, Flag-OSR1, Flag-SPAK, or siRNAs against SPAK and OSR1. To
determine the I-V relationship during zero-current clamp recordings, the clamp mode was shifted to the voltage clamp mode,
and the I/V curve was obtained by applying ramp pulses from 80 mV to 80 mV (0.8-mV/ms holding potential, near the resting
membrane potential). The I/V curves were analyzed in the initial bath solution containing 150-mM Cl (1) and in a solution
containing 4-mM Cl and 146-mM HCO3
 (2). Each reversal potential is marked with an arrow. WNK1 alone is sufficient for the
upregulation of the CFTR PHCO3/PCl.
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modulation via WNK1, we then examined the physical as-
sociation between CFTR and the truncated WNK1 proteins
using a semi pull-down assay (Figure 8). Cell lysates taken
from CFTR-expressing HEK293T cells were incubated with
recombinant glutathione S-transferase (GST)–tagged WNK1
proteins in media containing high (150 mM) and low
(0 mM) Cl concentrations and the amount of CFTR protein
bound to each truncated WNK1 was analyzed. Of interest,
the WNK1 kinase domain [WNK1(221–491)] associated
strongly with CFTR regardless of the Cl concentration. The
inclusion of the regions surrounding the kinase domain,including the WNK1 auto-inhibitory domain and a coiled-
coil domain [WNK1(1–665)], greatly reduced the binding
to CFTR in the high-Cl (150 mM) medium but not in the
low-Cl (0 mM) medium, suggesting that Cl inhibits the
physical association between WNK1 and CFTR through
these WNK1 regions. Collectively, these results imply that
the WNK1 N-terminal region mediates the upregulation of
CFTR PHCO3/PCl via a [Cl
]i-dependent physical association
with CFTR.
Because the kinase domain is critical for the upregula-
tion of the CFTR PHCO3/PCl (Figures 6 and 7) and for the
physical association between WNK1 and CFTR (Figure 8),
Figure 4. WNK1 increases the bicarbonate conductance (GHCO3) of CFTR. (A) In cells expressing CFTR alone, changing
bath solutions from a Cl -rich solution (1) to a HCO3

–rich solution (2) evoked reductions in anion channel conductance. (B) In
cells coexpressing WNK1, replacing bath solutions with a HCO3

–rich solution did not significantly reduce the slope
conductance. (C) A summary of results showed that WNK1 increased the HCO3
 conductance (GHCO3) of CFTR, when
normalized to each Cl current (GHCO3/GCl, G2/G1, n ¼ 20 for CFTR alone and n ¼ 21 for CFTR þ WNK1). Data are presented
as the mean ± SEM. **P < .01.
2020 WNK1, CFTR HCO3
 Permeability, and Pancreatitis 85we investigated whether the WNK1 kinase activity is
involved in CFTR regulation (Figures 9 and 10) using a
kinase-dead WNK1(D368A) mutant that is catalytically
inactive and does not phosphorylate downstream SPAK and
OSR1.26 Of note, the kinase-dead D368A mutation did notFigure 5. Surface expression of CFTR with depletion or over
transfected with plasmids expressing WT CFTR and (1) scrambl
the surface biotinylation assays were performed. Representative
experiments are shown in panel B (n ¼ 5). Cell surface–specifi
cytosolic protein aldolase A in the biotinylated fraction. Neither d
cell-surface expression of CFTR. n.s., not significant.abolish the WNK1 effect on the upregulation of CFTR PHCO3/
PCl (Figures 9A and 10A; see summary in Figure 9H). In
addition, the WNK1(D368A) mutant retained the ability to
bind to CFTR at low [Cl]i (Figure 9I). A recent crystallo-
graphic study identified a Cl-sensing region in the WNK1expression of WNK1 in HEK293 cells. HEK293T cells were
ed RNA, (2) siRNA against WNK1, or (3) WNK1 plasmids, and
immunoblots are shown in panel A and a summary of multiple
c labelling of proteins was confirmed by the absence of the
epletion nor overexpression of WNK1 significantly altered the
Figure 6. The WNK1 kinase domain is critical for the upregulation of CFTR HCO3
L permeability. (A–G) The PHCO3/PCl
of CFTR was analyzed in HEK293T cells transfected with plasmids containing the WNK1 N-terminal PRD [WNK1(1–119)],
PRD þ NL [WNK1(1–221)], kinase domain [WNK1(221–491)], PRD þ NL þ kinase domain [WNK1(1–491)], and the remaining
C-terminal regions [WNK1(492–2126)]. The domain structure of human WNK1 is depicted in Figure 8A. Whole-cell currents
were measured after the activation of CFTR channels by cAMP (5-mM forskolin and 100-mM IBMX) using the same protocol
used in Figure 2. Representative voltage measurements are shown. To determine the I-V relationship during zero-current
clamp recordings (Figure 7, arrows indicate the time points used to measure the I-V relationship). (H) A summary of the
PHCO3/PCl values from zero-current clamp recordings is presented. Truncated WNK1 proteins containing the kinase domain
[WNK1(221–491) and WNK1(1–491)] increased the CFTR PHCO3/PCl. Bar-graph data are presented as the mean ± SEM. **P <
.01: difference from CFTR alone.
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prevents kinase autophosphorylation and activation.19 The
WNK1-L369F/L371F mutant has repeatedly been used to
induce Cl–insensitive constitutive activation of WNK1-
kinase activity.27 Mutagenesis of this region (L369F,
L371F, and L369F/L371F) did not affect the WNK1-
mediated regulation of CFTR PHCO3/PCl (Figures 9B–D and
10B–D) or the low [Cl]i-induced association betweenWNK1 and CFTR (Figure 9J). It has been shown that the
GXXXP motif in some proteins, such as NBCe1-B and NBCe2-
C, functions as an intracellular Cl sensor.28 The WNK1 N-
terminal region contains 2 putative GXXXP sites (G14A/
P18A and G274A/P278A); therefore, we examined their
functional significance. Single or double mutations in the 2
GXXXP sites did not affect CFTR PHCO3/PCl regulation
(Figures 9E-G and 10E–G). WNK1 association with CFTR
Figure 7. Current/voltage (I/V) relationship for the whole-cell current measurements in Figure 6A–G. (A-G) The I-V
relationship was measured at each time point marked in the corresponding panels of Figure 6A-G. The PHCO3/PCl of CFTR was
analyzed in HEK293T cells expressing truncated WNK1 proteins. To determine the current-voltage relationship during zero-
current clamp recordings, the clamp mode was shifted to the voltage clamp mode, and the I/V curve was obtained by
applying ramp pulses from 80 mV to 80 mV (0.8 mV/ms holding potential, near the resting membrane potential). The I/V
curves were analyzed in the initial bath solution containing 150-mM Cl (1) and in a solution containing 4-mM Cl and 146-mM
HCO3
 (2). Each reversal potential is marked an arrow. Truncated WNK1 proteins containing the kinase domain
[WNK1(221–491) and WNK1(1–491)] increased the CFTR PHCO3/PCl.
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sites (Figure 9J). Taken together, these results suggest that
WNK1 kinase activity and its known Cl–-binding sites are
not involved in the regulation of CFTR PHCO3/PCl.WNK1 N-Terminal Region Modulates the Ion
Selectivity of CFTR in Excised Patch Clamp
Recordings
Bi-ionic potential measurements based on whole-cell
recordings might contain erroneous signals, in particular,due to potential ion depletion or accumulation.29 To mini-
mize this problem, we measured the CFTR PHCO3/PCl in
excised patch clamp configurations using recombinant
WNK1 proteins. Although the kinase domain
[WNK1(221–491)] alone was sufficient to increase the CFTR
PHCO3/PCl in whole-cell recordings (Figures 6 and 7) and for
the association of WNK1 with CFTR in pull-down assays
(Figure 8), the recombinant WNK1(221–491) protein ten-
ded to form precipitates in patch solutions. Therefore, we
performed the excised patch recordings using the recom-
binant protein containing the WNK1 N-terminal regions
Figure 8. The WNK1 N-terminal region interacts with CFTR in a [ClL]i-dependent manner. (A) Schematic diagram of the
WNK1 constructs used in pull-down assays. (B, C) Semi–pull-down assays were performed with recombinant GST-WNK1
fragments and cell lysates prepared from HEK293T cells expressing CFTR. GST pull-down assays were done in Cl-free
and high-Cl (150 mM) media. Representative blots are shown in panel B), and a summary of CFTR pull-down values relative
to WNK1(221–491) protein at 0-mM Cl– is illustrated in panel C, n ¼ 4). The kinase domain of WNK1 strongly binds to CFTR
regardless of Cl concentration. The inclusion of regions surrounding the kinase domain [WNK1(1–665)] reduces the WNK1-
CFTR interaction in 150-mM Cl medium. Error bars are presented as the mean ± SEM. **P < .01: difference from
WNK1(221–491) at 0-mM Cl. AID, auto-inhibitory domain; CC, coiled-coil domain; FL, full-length; KD, kinase domain.
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experimental solutions. WNK1(1–491) showed Cl–sensi-
tive binding to CFTR with an IC50 value of 10.1 mM [Cl
],
and 84% of maximum CFTR binding activity was retained at
a 4-mM Cl concentration (Figure 11). In outside-out patch
clamp recordings, the addition of WNK1(1–491) to the
intracellular side of the pipette solution increased the CFTR
PHCO3/PCl (Figure 12A–C), recapitulating the findings of the
whole-cell recordings. More remarkably, the addition of
WNK1(1–491) to the bath solution (intracellular side) in
inside-out patch clamp recordings increased the CFTR
PHCO3/PCl in a dose-dependent manner (Figure 12D–F). The
EC50 value of WNK1(1–491) that was required for the CFTR
PHCO3/PCl increase was 3.2 mM (95% confidence interval,
2.3–4.2 mM) at 10-mM [Cl]i and shifted to 1.1 mM (95%
confidence interval, 0.2–2.0 mM) at 4-mM [Cl]i, indicatingthat the EC50 value was left-shifted and the WNK1 effect
was augmented at lower [Cl]i (Figure 12F).
An increase in the PHCO3/PCl of some anion channels is
associated with increases in the pore size and the dielectric
constant (ε) of the selectivity filter.16 Because the WNK1 N-
terminal region increased the CFTR PHCO3/PCl (Figures 6 and
12), we next examined whether WNK1(1–491) increased the
pore size and ε of the CFTR selectivityfilter (Figure13). Inside-
out recordings with control GST and WNK1(1–491) proteins
showed that WNK1(1–491) increased the CFTR PHCO3/PCl,
whereas the addition of GST did not (Figure 13A–C). The ion
selectivity ofmost anion channels is principally determined by
a combination of the pore size (area exclusion) effect and the
anion transfer free-energy (dehydration-energy) effect. It has
been shown that the area exclusioneffect dominantly affects I
permeation through theCFTRchannel because of the large size
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pore.16 On the other hand, the dehydration-energy effect
mainly determines NO3
 permeation, because NO3
 is a
medium-sized, symmetrically charged ion. Accordingly, the
CFTR I permeability is reported to be less than the CFTR Cl
permeability because of a large area exclusion effect, while the
CFTR NO3
 permeability is greater than the CFTR Clpermeability because of a small dehydration-energy pen-
alty.16,30 Similar to previous reports,16,30 the relative perme-
ability of I (PI/PCl) was only 0.59 ± 0.04 in our inside-out
recordings. Notably, this value was increased to 0.84 ± 0.04
by WNK1(1–491) (Figure 13D–F), suggesting an increase in
the CFTR pore size, which relieves the energy barrier of area
exclusion. We next examined the effect of WNK1(1–491) on
90 Kim et al Cellular and Molecular Gastroenterology and Hepatology Vol. 9, No. 1NO3
 permeability. The relative NO3
 permeability (PNO3/PCl)
was 1.92 ± 0.17 under the control condition and was reduced
to 1.42 ± 0.08 byWNK1(1–491) (Figure 13G–I), indicating an
increase in the pore size of CFTR, which increases the ε of the
CFTR selectivity filter and thus relieves the dehydration-
energy penalty difference between NO3
 and Cl. These re-
sults imply that the WNK1 N-terminal region modulates the
ion selectivity of CFTR by increasing the size of the CFTR
functional pore.
Next, we examined the effects of WNK1(1–491) on CFTR
channel conductance using inside-out configurations
(Figure 14). Macroscopic CFTR currents were measured in
symmetrically Cl–-rich (150 Cl–) and HCO3
–-rich (146 HCO3
– þ
4 Cl–) solutions. Notably, addition of WNK1(1–491) to the bath
(intracellular side) increased CFTR HCO3
– conductance (GHCO3)
by 76 ± 13% (n ¼ 9) (Figure 14C and D), whereas the same
WNK1(1–491) did not affect the CFTR Cl– conductance (GCl)
(Figure 14A and B).
Effects of WNK1 on CFTR Single-Channel
Activity
We analyzed the effects of WNK1 on CFTR single-channel
activity to confirm the permeability and conductance changes
observed in whole-cell and macroscopic excised patch re-
cordings. Representative inside-out patch traces and I-V
measurements are shown in Figure 15A–D, and the sum-
marized results are presented in Figure 15E–H. WNK1 did
not significantly affect the single-channel activity of the CFTR
Cl current, including the single-channel conductance and
open probability (Po) (Figure 15A, B, and E–H). Changing the
bath (intracellular) side to a HCO3
-rich solution evoked
a þ32 mV shift of reversal potential (PHCO3/PCl ¼ 0.25).
Importantly, the addition of 10-mM WNK1(1–491) to the
bath induced a negative shift of reversal potential leading
to þ14 mV (PHCO3/PCl ¼ 0.56), which again indicates a
WNK1-induced increase in PHCO3/PCl (Figure 15D). Of inter-
est, WNK1 also increased single-channel conductance, Po, and
the open dwell time of CFTR HCO3
 currents (Figure 15E–H).Molecular Pathogenic Mechanisms of CFTR
Mutations Associated With Pancreatitis
A recent study indicated that 9 CFTR mutants that
impair WNK1-regulated HCO3
 permeation are associated
with pancreatitis, rhinosinusitis, and male infertility.6 ToFigure 9. (See previous page). WNK1 kinase activity and know
CFTR HCO3
L permeability. (A–H) The PHCO3/PCl of CFTR was
Plasmids expressing the kinase-dead WNK1 mutant (D368A)
binding regions of the kinase domain (L369F, L371F, and L369F
double mutant G14A/P18A/G274A/P278A) were co-transfected
CFTR channels by cAMP (5-mM forskolin and 100-mM IBMX) usi
and current measurements are shown in panels A–G and Figure
I-V relationship). A summary of the PHCO3/PCl values from zero-
data are presented as the mean ± SEM. **P < .01: difference
ference when comparted to WT WNK1. (I) Semi pull-down ass
bearing the kinase-dead D368A mutation and cell lysates prepar
condition. Three independent experiments displayed similar res
binant GST-WNK1(1–491) bearing mutations in the putative Cl-
expressing CFTR under the 0-mM and 150-mM Cl conditionsunderstand the molecular basis of these pathogenic CFTR
mutants, we first examined the ability of CFTR mutants to
bind WNK1 using a semi–pull-down assay. Two CFTR mu-
tations, R74Q and R75Q, located in the N-terminal “elbow
helix” region caused significant reductions in the WNK1-
CFTR association (Figure 16A and B). Defects in the
WNK1-CFTR association, as well as intrinsic defects in the
CFTR channel pore, can impair the WNK1-regulated HCO3

permeation of CFTR. We chose R74Q and L997F as
representative mutations that induce defects in the CFTR
HCO3
 channel by WNK1-related and nonrelated mecha-
nisms, respectively. We then performed inside-out patch
recordings with WNK1(1–491). In macroscopic current an-
alyses, the EC50 value of WNK1(1–491) that was required
for increased CFTR PHCO3/PCl at 4 mM [Cl
]i was 0.7 mM
(95% confidence interval, 0.2–1.2 mM) in the control wild-
type (WT) CFTR, and this value was right-shifted to 2.9
mM (95% confidence interval, 1.8–4.1 mM) in the CFTR
R74Q mutant (Figure 16C–E). On the other hand,
WNK1(1–491) at concentrations up to 10 mM did not in-
crease CFTR PHCO3/PCl in the CFTR L997F mutant
(Figure 16C and F). These results support the notion that
R74Q impairs the regulated HCO3
 permeation of CFTR by
inhibiting WNK1-CFTR association, while L997F causes




 are the 2 most abundant anions that can
be the charge carrier of CFTR, although diverse anions
permeate through the anion channels of animal cells.
Therefore, changes in CFTR HCO3
 permeability and
conductance that determine the amount of HCO3

flux
across the apical membrane of CFTR-expressing epithelia
have important physiological and pathological implications.
Our integrated molecular and physiological approach
revealed that the N-terminal region of WNK1 senses [Cl]i
and regulates CFTR PHCO3/PCl by physically associating or
dissociating with CFTR. Whole-cell, outside-out, and inside-
out patch clamp studies indicated that WNK1 fragments
containing the kinase domain are sufficient for modulating
the ion selectivity and conductance of CFTR. Pull-down as-
says with recombinant WNK1 fragments showed that the
WNK1 kinase domain physically interacts with CFTR andn Cl–-binding sites are not involved in the upregulation of
analyzed in HEK293T cells expressing WNK1 mutant proteins.
and WNK1 mutants bearing mutations in the putative Cl-
/L371F) and GXXXP motifs (G14A/P18A, G274A/P278A, and
. Whole-cell currents were measured after the activation of
ng the same protocol used in Figure 2. Representative voltage
10 (arrows indicate the time points that were used to measure
current clamp recordings is presented in panel H. Bar-graph
from CFTR alone. WNK1 mutants exhibited no statistical dif-
ays were performed with recombinant GST-WNK1(221–491)
ed from HEK293T cells expressing CFTR under the 0-mM Cl
ults. (J) Semi pull-down assays were performed with recom-
binding regions and cell lysates prepared from HEK293T cells
. Three independent experiments displayed similar results.
Figure 10. Current/voltage (I/V) relationship for the whole-cell current measurements in Figure 9A–G. (A-G) The I-V
relationship was measured at each time point marked in the corresponding panels of Figure 9A-G. The PHCO3/PCl of CFTR was
analyzed in HEK293T cells expressing the kinase-dead WNK1 mutant (D368A) and WNK1 mutants bearing mutations in the
putative Cl-binding regions of the kinase domain (L369, G370, and L371) and GXXXP motifs (G14A/P18A and G274A/P278A).
To determine the current-voltage relationship during zero-current clamp recordings, the clamp mode was shifted to the
voltage clamp mode, and the I/V curve was obtained by applying ramp pulses from 80 mV to 80 mV (0.8 mV/ms holding
potential, near the resting membrane potential). The I/V curves were analyzed in the initial bath solution containing 150-mM Cl
(1) and in a solution containing 4-mM Cl and 146-mM HCO3
 (2). Each reversal potential is marked with an arrow. The kinase-
dead D368A mutation and mutations in the known Cl-binding sites of WNK1 did not affect the ability of WNK1 to upregulate
the CFTR PHCO3/PCl.
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CFTR association in a Cl-dependent manner.
A notable finding in the present study is that the WNK1
kinase domain, but not its kinase activity, is involved in the
regulation of CFTR ion selectivity. In many cases, WNKs
regulate membrane transport proteins by phosphorylating
downstream STE20-like kinases such as OSR1 and SPAK.31
In those cases, intact kinase activity is critical for the
regulation of the membrane transporters, and the loss of thekinase activity abolishes the WNK-mediated regulation.
However, in the present study, the kinase-dead WNK1
D368A mutation did not affect the ability of WNK1 to
upregulate CFTR PHCO3/PCl (Figure 9). This result is
compatible with the finding that STE20-like kinases are not
required for CFTR regulation (Figure 2). It has been sug-
gested that WNKs regulate the expression and function of
some transporters via a kinase activity–independent




tions. Semi pull-down as-
says were performed with
recombinant GST-WNK1




were done at various Cl–
concentrations (0, 4, 10,
20, 40, and 150 mM) by
replacing Cl– with gluco-
nate (see Methods).
Representative blots are
shown in panel A, and a
summary of CFTR pull-
down values (n ¼ 7) rela-
tive to WNK1(1–491)
protein at 0-mM Cl– is
illustrated in panel B. The
IC50 value of [Cl
–] that in-
hibits the binding between
GST-WNK1(1–491) and
CFTR was calculated as
10.1-mM (B, inset). Data
are presented as mean ±
SEM.
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gions, including the kinase domain, mediate the inhibition of
ROMK1 via a noncatalytic mechanism.25 In addition, the
WNK kinase activity is not required for the WNK/SPAK-
mediated regulation of NBCe1-B.34 Taken together with
the present results for CFTR, the noncatalytic but kinase
domain-dependent mechanism of regulation appears to be
one of the general mechanisms by which WNKs regulate
target proteins.
A crystallographic study of the recombinant WNK1 ki-
nase domain identified a Cl binding site within the kinase
domain where Cl binding inhibits the catalytic activation of
WNK1.19 Mutations at this site (L369F, L371F, and L369F/
L371F) affected neither the ability of WNK1 to regulate the
CFTR PHCO3/PCl nor the [Cl
]i-dependent association of
WNK1 with CFTR (Figure 9). These results are in agreement
with the idea that WNK1 regulates CFTR ion selectivity via a
noncatalytic mechanism and suggest that the [Cl]i-depen-
dence of the association between WNK1 and CFTR is not
related to the kinase activity. Our results indicate that theoverall [Cl]i-dependence of the effects of WNK1 on CFTR
originates from potential Cl-sensing sites in the PRD þ NL
(aa. 1–221) and auto-inhibitory domain þ first coiled-coil
(aa. 492–665) regions (Figure 8). The binding of Cl to
these regions appears to induce structural changes that
inhibit the physical association between the WNK1 kinase
domain and CFTR.
The precise WNK1-binding sites of CFTR need to be
addressed in future studies. Experiments with pancreatitis-
causing CFTR mutants revealed that R74 and R75, located in
the first elbow helix region of CFTR, are critically involved in
the WNK1-CFTR association (Figure 16). Notably, a
computational protein-protein docking analysis using the
Protein Data Bank-deposited structures of hCFTR,35 zebra-
fish CFTR in the phosphorylated, adenosine triphosphate
(ATP)–bound conformation,35 and the WNK1 kinase
domain36 showed that WNK1 S231–T234 and I384–E388
potentially bind to intracellular hCFTR regions near
R74–R75 (Figure 17). According to a 3.9-Å cryo-EM struc-
ture of human CFTR, the handle-like first elbow helix is
Figure 12. Measurements of CFTR PHCO3/PCl in excised patch clamp recordings using recombinant WNK1 proteins.
(A–C) The membrane potential was measured in outside-out patch clamp recordings using patch membranes prepared from
HEK293T cells expressing CFTR. The low-Cl (10 mM) pipette solution contained the catalytic subunit of protein kinase A
(PKA, 10 U/mL) and 3-mM MgATP to activate CFTR. The addition of recombinant WNK1(1–491) (3 mM) to the pipette solution
increased the CFTR PHCO3/PCl. Representative voltage measurements are shown in panels A and B and a summary of PX/PCl
values from zero-current clamp recordings is presented in panel C. Data are presented as the mean ± SEM (CFTR alone; n ¼ 7
and CFTRþWNK1 (1–491); n ¼ 5). **P < .01: difference from CFTR alone. (D–F) Membrane potential was measured in inside-
out patch clamp recordings using patch membranes prepared from HEK293T cells expressing CFTR. The low-Cl (4 mM or 10
mM) bath solution (intracellular side) contained the catalytic subunit of protein kinase A (PKA, 10 unit/mL) and 3-mM MgATP to
activate CFTR. The addition of recombinant WNK1(1–491) (1w10 mM) to the bath solution increased the CFTR PHCO3/PCl in a
dose-dependent manner. (F) The dose-response curve was left-shifted at 4-mM [Cl]i the relationship of the PHCO3/PCl values
from zero-current clamp recordings and WNK1 (1–491) is presented. Data are presented as the mean ± SEM (n ¼ 7).
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contacts a proximally located lasso motif that has been
suggested to play a role in CFTR gating and regulation of the
R domain.35 Taken together, it appears that the binding of
WNK1 to this CFTR region favors the open structure of the
CFTR pore to facilitate HCO3
 permeation.
An increase in the pore diameter of anion channels in-
creases the PHCO3/PCl by alleviating the energy barrier of
area exclusion and, more importantly, by reducing the
dehydration-energy penalty due to an increase in the ε ofthe pore region.16 Results in Figure 13 support the notion
that WNK1 may increase the CFTR anion channel pore
diameter. In addition to the reductions in the energy bar-
riers of area exclusion and dehydration, CFTR channel-
specific factors seem to be involved in the WNK1-induced
increase in CFTR PHCO3/PCl. We frequently observed that
WNK1 stimulation caused CFTR PHCO3/PCl to reach values
>1. Simple reductions in the energy barrier of area exclu-
sion and the difference in dehydration penalty between
HCO3
 and Cl can only explain increases in the CFTR
Figure 13. Measurements of CFTR PI/PCl and PNO3/PCl in inside-out patch clamp recordings with recombinant WNK1
proteins. The membrane potential was measured in inside-out patch clamp recordings using patch membranes prepared from
HEK293T cells expressing CFTR. The low-Cl (4 mM) bath solution (intracellular side) contained the catalytic subunit of PKA
(10 U/mL) and 3-mM MgATP to activate CFTR. The CFTR PHCO3/PCl (A-C), PI/PCl (D-F), and PNO3/PCl (G-I) values were
analyzed with changing ionic compositions of the bath solution using a protocol as detailed in the Materials and Methods
section. The addition of recombinant WNK1(1–491) (3 mM) to the bath solution increased PI/PCl and reduced PNO3/PCl
Representative voltage measurements are shown in panels A, B, D, E, G, and H, and summaries of the respective PX/PC
values from zero-current clamp recordings are presented in panels C, F, and I, respectively. Bar graph data are presented as
the mean ± SEM. *P < .05, **P < .01: difference from CFTR alone.
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Figure 14. Measurements of CFTR conductance in inside-out patch clamp recordings with recombinant WNK1
proteins. (A, B) Macroscopic currents were recorded from inside-out membrane patches using symmetrically Cl-rich (150
mM) solutions in CFTR-expressing HEK293T cells. Patch membranes were prepared from HEK293T cells expressing CFTR.
CFTR currents were activated by addition of the catalytic subunit of protein kinase A (PKA, 10 unit/mL) to a 3-mM MgATP
containing bath solution (intracellular side). The I-V relationship was obtained by applying ramp pulses from 80 to þ80 mV
(0.8 mV/ms) at resting state (basal) and after additions of PKA (Control) and PKA þ WNK1(1–491) to the bath solution.
Representative traces are shown in panel A) and a summary of relative CFTR currents at –60 mV (normalized by control GCl)
are shown in panel B (n ¼ 10). (C, D) Macroscopic CFTR currents were recorded from inside-out membrane patches using
symmetrically HCO3
–-rich (146 HCO3
– þ 4 Cl–) solutions. The I-V relationship was obtained at resting state (basal) and after
additions of PKA (Control) and PKA þ WNK1(1–491) to the bath solution. Representative traces are shown in panel C and a
summary of relative CFTR currents (normalized by control GHCO3) are shown in panel D (n¼ 9). Data are presented as the mean
± SEM. **P < .05: difference from CFTR alone.
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favor the permeation of HCO3
 should play a role in the
mechanism by which WNK1 increases the CFTR PHCO3/PCl to
values >1. Another interesting finding, the mechanism of
which needs to be examined in future studies, is the in-
creases in the conductance and Po of CFTR HCO3
 channel.
Increase in CFTR GHCO3 as well as PHCO3/PCl has paramount
importance in augmenting HCO3

flux across the apical
membrane of epithelial cells.3,11,37 According to the dielec-
tric tunnel theory of anion selectivity, anions that exhibit
higher permeability may have a decreased conductance
because they bind more tightly in the channel.38 However, in
the present study, the CFTR HCO3
 permeability increase is
not coupled with the HCO3
 conductance decrease. Collec-
tively, these findings indicate that WNK1 exerts complexeffects on CFTR HCO3
 channel activity in addition to pore
dilation.
In the present study, excised cell-free patch experiments
revealed that WNK1 affects the ion selectivity of CFTR in a
dose-dependent and [Cl]i-dependent manner
(Figure 12D–F). Measurements of the bi-ionic potentials
using whole-cell recordings might contain erroneous results
because of the series resistance and ion depletion/accu-
mulation problems.29 Importantly, inside-out and outside-
out patch experiments (Figure 12), in which the ion deple-
tion or accumulation problems are minimal, produced
results comparable to those of whole-cell recordings
(Figures 2 and 6). Furthermore, we used a zero-current
clamping mode to measure the membrane potentials dur-
ing whole-cell recordings and used those values for all
Figure 15. Effects of WNK1 on CFTR single-channel activity. (A, B) Single-channel current recordings were performed in
excised, inside-out patches in HEK293T cells with addition of WNK1(1–491) (10 mM). Representative (A) inside-out patch
traces and (B) I-V measurements with a 150-mM Cl–containing solution in the bath (intracellular) side. (C, D) Representative
(C) inside-out patch traces and (D) I-V measurements in which the bath side was changed to a HCO3

–rich solution. Arrows
indicate Erev. (E-H) A summary of single-channel conductance (E), open probability (Po, F), open dwell time (G), and closed
dwell time (H) (n ¼ 10 for Bath 150-mM Cl, n ¼ 9 for Bath 146-mM HCO3 þ 4-mM Cl). Bar-graph data are presented as the
mean ± SEM. *P < .05, **P < .01.
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change problems caused by series resistance.39 Last, re-
ductions in CFTR anion channel conductance may alter
membrane potential when the recorded currents arecontaminated with considerable amounts of background or
leak currents. However, as shown in Figure 1, up to 50%
inhibition of GCFTR showed no discernible changes in
membrane potential. Therefore, an w50% reduction of
Figure 16. Molecular pathogenic mechanisms of CFTR mutations that impair WNK1-regulated HCO3
L permeation.
(A, B) Semi–pull-down assays were performed with recombinant GST-WNK1(1–491) and cell lysates prepared from HEK293T
cells expressing CFTR. The GST pull-down assays were performed in Cl-free and high-Cl (150 mM) media. The pull-down
results under the 150-mM and 0-mM Cl conditions using WT CFTR-expressing cell lysates were used as negative and
positive controls, respectively. Representative blots are shown in panel A, and a summary of CFTR pull-down values relative to
those of WT CFTR at 0-mM Cl– is illustrated in panel B (n ¼ 6). Two CFTR mutations, R74Q and R75Q, reduced WNK1-CFTR
associations. (C–F) Membrane potential was measured in inside-out patch clamp recordings using patch membranes pre-
pared from HEK293T cells expressing WT and mutant CFTRs. Inside-out patch clamp recordings were performed using the
same protocols used in Figure 12D. A summary of 5 independent experiments is shown in panel C, and representative traces
are shown in panels D–F. Higher concentrations of WNK1(1–491) increased the PHCO3/PCl of the CFTR R74Q mutant, but not
that of the CFTR L997F mutant. Bar-graph data are presented as the mean ± SEM. **P < .01: difference from CFTR alone.
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-rich solutions (Figure 4) is not anticipated
to influence the membrane potential measurements. These
technical maneuvers and results suggest that our data were
not greatly affected by problems resulting from bi-ionic
potential measurements.The CFTR-expressing epithelial cells in the gastrointes-
tinal, respiratory, and genitourinary systems secrete HCO3
-
containing fluids.2,7 A number of studies have shown that
HCO3
 in secreted fluids has diverse physiological roles,
such as the prevention of mucin aggregation and mucus
Figure 17. Structural
model for the MD-
equilibrated complex be-
tween hCFTR and WNK1
kinase domain in the
presence of lipid bilayer.
The R74 (purple balls) and
R75 (blue balls) residues
from hCFTR participate in
the binding interface. The
figure displays the hCFTR-
WNK1 complex predicted
by ClusPro, after equili-
bration in the MD simula-
tion system where it is
embedded into the mem-
brane lipids (lines with their
phosphorus atoms shown
in tan spheres) and sol-
vated by 0.1 M NaCl solu-
tion. The snapshot was
taken after 100-ns MD
simulations. The inset
figure shows a closeup
view of interfacial in-
teractions. WNK1 residues
at the interface include
S231, F232, K233, T234,
and I384, G385, T386 and
E388.
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organs, the generation of an optimal pH environment for the
enzymes and structural proteins dissolved in secreted
fluids, and the prevention of overt infection and inflamma-
tion via the antibacterial properties of HCO3
.2,40,41 Conse-
quently, aberrant HCO3
 secretion caused by generalized
defects in CFTR function, such as defective cell-surface
expression and channel gating, is associated with a wide
spectrum of diseases including cystic fibrosis, bronchiec-
tasis, congenital bilateral absence of the vas deferens, and
pancreatitis.2,42,43 Many epithelial cells, including those in
sweat glands and airways, retain >20-mM [Cl]i mostly due
to the basolateral NKCC activity.11,44,45 On the contrary,
human and guinea pig pancreatic duct cells have very low or
no NKCC activity, and their [Cl]i can be decreased to w5
mM during cAMP stimulations,2,14,22 suggesting that a low[Cl]i-induced WNK1 activation may substantially function
in these cells.
Of particular interest is a recent study showing that
CFTR mutants with selective defects in WNK1-regulated
HCO3
 permeation increase the risks of pancreatitis, rhi-
nosinusitis, and male infertility.6 Interestingly, the R74Q
and L997F mutations exhibit almost normal CFTR Cl
channel activity,6 implying that CFTR functions other than
Cl channel activity may be critical for the pathogenesis.
The disease-causing R74, R75, and L997 CFTR loci are
evolutionarily conserved and if mutated, impaired func-
tion would be expected. In fact, a previous study exam-
ining the clinical phenotypes of complex heterozygous
individuals with L997F mutation found that L997 is
highly conserved among species and suggested that the
L997F mutation may exert a greater influence on CFTR
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electrophysiological results support the idea that R74Q
reduces CFTR HCO3
 channel activity by inhibiting
physical associations between WNK1 and CFTR, whereas
L997F does so by causing other intrinsic defects in the
channel. The discoveries described in the present study
will help investigators to develop better drugs and help
physicians to treat patients with diseases caused by
aberrant CFTR-mediated HCO3
 transport, such as
chronic pancreatitis.
Materials and Methods
Plasmids, Small Interfering RNAs, and Cell
Culture
The mammalian-expressible plasmids for rWNK1,
mSPAK, hOSR1, and hCFTR were previously described.14,16
HEK293T cells were cultured in Dulbecco’s modified Eagle
medium–high glucose (Invitrogen, Carlsbad, CA) supple-
mented with 10% (v/v) fetal bovine serum, 100-U/mL
penicillin, and 0.1-mg/mL streptomycin. The WNK1
fragments were subcloned into a pCMV-myc plasmid or
pGEX-4T1 plasmid using polymerase chain reaction
amplification. The WNK1 mutant and CFTR mutant plas-
mids were generated using polymerase chain
reaction–based site-directed mutagenesis. The small
interfering RNAs against OSR1 and SPAK were purchased
from GE Dharmacon (Lafayette, CO). Plasmids were tran-
siently transfected into cells using Lipofectamine Plus
(Invitrogen). siRNAs were transiently transfected into
HEK293T cells using Lipofectamine 2000 (Invitrogen). An
average transfection rate over 90% was confirmed by co-
transfection with a plasmid expressing green fluorescent
protein (GFP).
Antibodies and Immunoblot Analysis
The antibodies against SPAK (#2281; Cell Signalling
Technology, Danvers, MA), OSR1 (#3729; Cell Signalling
Technology), CFTR (M3A7; Upstate Biotechnology, Wal-
tham, MA), Flag epitope (F3165; Sigma-Aldrich, St. Louis,
MO), Myc epitope (sc-40; Santa Cruz Biotechnology, Santa
Cruz, CA), anti-Aldolase A (ab78339; Abcam, Cambridge,
United Kingdom), and b-actin (sc-1616; Santa Cruz
Biotechnology) were obtained from commercial com-
panies. For immunoblot analysis, transfected HEK293T
cells were washed 3 times with ice-cold phosphate-buff-
ered saline and then harvested with lysis buffer consist-
ing of 50-mM Tris-HCl (pH 7.4), 150-mM NaCl, 10% (v/v)
glycerol, 1% (v/v) Triton X-100, 5-mM EDTA, 5-mM
EGTA, and complete protease inhibitor cocktail (Roche
Applied Science, Mannheim, Germany). The cells were
centrifuged, the cell lysates were diluted in 2 sodium
dodecyl sulfate (SDS) sample buffer, and the protein
samples were separated by SDS-polyacrylamide gel elec-
trophoresis. The separated proteins were transferred to a
nitrocellulose membrane and blotted with the appropriate
primary and secondary antibodies. Protein bands were
detected by enhanced chemiluminescence (Amersham
Biosciences, Piscataway, NJ).GST-Tagged WNK1 Proteins and Pull-Down
Assays
The glutathione S-transferase (GST) pull-down assays
were performed by collecting binding partners of the GST-
tagged proteins as described previously.23 The GST-tagged
recombinant proteins were expressed in Escherichia coli
BL21 transformed with pGEX-4T1-empty or pGEX-4T1-
WNK1 fragment vector and purified with glutathione-
Sepharose 4B (Amersham Biosciences). For the pull-down
assays, HEK293T cells transfected with WT or mutant
CFTR plasmids were harvested with a lysis buffer contain-
ing 50-mM Tris-Cl (pH 7.4; containing 41.2-mM free Cl),
109.8-mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100,
5-mM EDTA, 5-mM EGTA, and a complete protease inhibitor
cocktail (Roche Applied Science). The 0-, 4-, 10-, 20-, and 40-
mM Cl–containing lysis buffers were prepared by replacing
Cl with an equimolar concentration of gluconate using
Naþ-gluconate and Tris-gluconate. The harvested lysate
supernatants were mixed with GST-WNK1 fragments bound
to glutathione-Sepharose beads and incubated overnight at
4C. The bead complexes were washed 3 times, eluted in a
2 sample buffer, and immunoblotted as described.
For the patch clamp experiments, recombinant GST-
WNK1 fragment proteins were eluted with GST-elution
buffer consisting of 50-mM Tris-HCl, 150-mM NaCl, 50-
mM GSH, 1-mM DTT, and complete protease inhibitor
cocktail (Roche Applied Science) (pH 8.0). The eluted GST-
WNK1 fragment proteins were dialyzed with Slide-A-Lyzer
dialysis cassettes (Thermo Fisher Scientific, Waltham, MA).
Surface Biotinylation Assay
After transfection with the indicated plasmids, HEK293T
cells were washed 3 times with phosphate-buffered saline.
The plasma membrane proteins were biotinylated by gently
shaking the cells in a borate buffer containing sulfo-NHS-SS-
biotin (Thermo Fisher Scientific, 21331) for 30 minutes.
After the biotinylation reaction was complete, the cells were
washed extensively with quenching buffer (1% bovine
serum albumin solution) to remove excess biotin, followed
by 2 phosphate-buffered saline washes. The cells were lysed
with lysis buffer (50-mM Tris-HCl, pH 7.4, 150-mM NaCl, 1%
[v:v] Nonidet P-40, 0.25% [v:v] sodium deoxycholate, and a
complete protease inhibitor mixture) followed by overnight
incubation at 4C with an avidin solution (UltraLink
Immobilized NeutrAvidin Beads 10%; Fisher Scientific;
53150). Avidin-bound complexes were pelleted (15,700 g,
20 minutes) and washed 3 times with lysis buffer. The
biotinylated protein was then eluted at 37C in a 2 SDS
sample buffer for 40 minutes. The eluted protein was
separated by SDS-polyacrylamide gel electrophoresis, elec-
trotransferred, and immunoblotted with the indicated
antibodies.
Electrophysiology
Whole-Cell Recordings. Whole-cell recordings were per-
formed on CFTR transfected HEK293T cells as previously
described.47 Cells were transferred to a bath mounted on
the stage of an inverted microscope (IX71; Olympus, Tokyo,
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electrophysiological recordings. Capillary glass pipettes
were prepared using a conventional micropipette puller (P-
97; Sutter Instrument, Novato, CA). Patch pipettes were
polished with a microforge to a resistance of w2–4 MU in
bath solutions that were connected to the head stage of a
patch clamp amplifier (Axopatch-200B; Molecular Devices,
Sunnyvale, CA, USA). The whole-cell patch was achieved by
rupturing the membrane after giga ohm sealing. The bath
solution was perfused at 5 mL/min and the voltage and
current recordings were performed at room temperature
(21–23C). In these experiments, a reference electrode was
placed in a chamber containing a 3 M KCl solution, which
was connected to the bath via a 1.5% (wt/vol) salt agar
bridge. The bath solution contained (in mM) 146 N-methyl-
D-glucamine chloride (NMDG-Cl), 1 CaCl2, 1 MgCl2, 5
glucose, and 10 HEPES adjusted to pH 7.4 with NMDG. The
high HCO3
–containing bath solution was prepared by
replacing NMDG-Cl with an equimolar concentration of
choline bicarbonate. The high HCO3
–containing solution
was continuously gassed with 95% O2 and 5% CO2 (pH 8.2),
which is comparable to the ionic composition of human
pancreatic juice.14 It has been shown that changes in pH and
CO2 concentrations do not significantly affect CFTR PHCO3/
PCl values.
16 The low Cl–containing pipette solutions were
prepared by replacing Cl with an equimolar concentration
of gluconate. The standard gluconate solution (10-mM Cl)
contained (in mM) 140 NMDG-gluconate, 8 NMDG-Cl, 5
EGTA, 1 MgCl2, 3 MgATP, and 10 HEPES (pH 7.4). CFTR
currents were activated by cAMP (5-mM forskolin and 100-
mM 3-isobutyl-1-methylxanthine [IBMX]). pClamp 10.2 and
Digidata 1550B (Molecular Devices) were used to acquire
data and apply command pulses. The currents were filtered
at 2 kHz and sampled at 500 Hz. PHCO3/PCl was determined
from the zero-current clamped reversal potential shift
[DErev ¼ Erev(HCO3) – Erev(Cl)], induced by replacing the
extracellular Cl with HCO3
 and using the Goldman-
Hodgkin-Katz equation. During the zero-current clamp
recording, we occasionally applied a ramp pulse (80
to þ80 mV, 0.8-mV/ms holding potential, near the resting
membrane potential) to obtain the I-V relationship to
confirm the characteristics of the measured currents. For
the anion permeability test, individual data were corrected
by measuring the offset potential shift induced by the
replacement of the anion solution after each
experiment.6,14,16
Macroscopic Excised Patch Experiments. For recording
of macroscopic currents in excised patch clamp experi-
ments, pipettes with a free-tip resistance of w2–5 MU
were used. In outside-out patch recordings, the low
Cl––containing pipette solutions were prepared by replacing
Cl– with an equimolar concentration of gluconate as
described previously. The ATP (3 mM)-containing pipette
solutions also contained the catalytic subunit of protein ki-
nase A (PKA) (10 U/mL; Promega, Madison, WI, USA) to
activate CFTR currents. The bath solution contained (in mM)
146 NMDG-Cl, 1 CaCl2, 1 MgCl2, 5 glucose, and 10 HEPES
(pH 7.4). The high HCO3
–containing bath solution wasprepared by replacing NMDG-Cl with an equimolar con-
centration of choline bicarbonate. For outside-out patch
recording, we first selected cells showing PKA-activated
CFTR currents at whole-cell configurations. Afterward,
these patches were made to outside-out patches by moving
the pipette away from the cell. To determine the I-V rela-
tionship during zero-current recordings, the clamp mode
was shifted to voltage clamp mode, and the I-V relationship
was obtained by applying a ramp pulse from –80 to þ80 mV
(0.8 mV/ms holding potential, near the resting membrane
potential). In inside-out patch clamp recordings, the pipette
solution (extracellular side) contained (in mM) 146 NMDG-
Cl, 1 MgCl2, 1 CaCl2, 10 Glucose, and 10 HEPES (pH 7.4). The
initial high Cl–containing bath solution (intracellular side)
contained (in mM) 148 NMDG-Cl, 1 MgCl2, 3 MgATP, 5
EGTA, and 10 HEPES, and were adjusted to pH 7.4 using
NMDG. The high HCO3
–containing bath solution was pre-
pared by replacing NMDG-Cl with an equimolar concentra-
tion of choline bicarbonate. The CFTR channel was activated
by the addition of the catalytic subunit of PKA (10 U/mL) to
the ATP (3 mM)-containing bath solution. For anion
permeability measurements in Figure 12, 150 Cl in the
bath solution was replaced with 146 X þ 4 Cl, where X– is
the substitute anion (I, NO3
, or HCO3
 in the form of
NaX). The Naþ permeability was low and did not signifi-
cantly alter under all experimental conditions (PNa/PCl w
0.08), and thus the PX/PCl values were not corrected for the
Naþ permeability. The macroscopic CFTR currents were
filtered at 2 kHz and sampled at 500 Hz.
Single-Channel Recording. Glass coverslips containing
cells co-transfected with hCFTR and GFP were placed in a
chamber. Single-channel current recordings were done in
excised, inside-out patches in HEK293T cells, as reported
earlier.47 Electrode resistance was kept at 15–20 MU for
single-channel recordings. The holding potential used in
the single-channel CFTR recordings was –60 mV; in some
experiments, the membrane potential was held from –100
to þ100 mV for the estimation of the I-V relationship. The
pipette solution (extracellular side) contained (in mM)
146 NMDG-Cl, 1 MgCl2, 1 CaCl2, 10 Glucose, and 10 HEPES
(pH 7.4). The initial high Cl–containing bath solution
(intracellular side) contained (in mM) 148 NMDG-Cl, 1
MgCl2, 3 MgATP, 5 EGTA, and 10 HEPES (pH 7.4). The high
HCO3
–containing bath solution was prepared by replac-
ing NMDG-Cl with an equimolar concentration of choline
bicarbonate. The CFTR channel was activated by the
addition of the catalytic subunit of PKA (10–40 U/mL,
Promega), adjusting the initial Po to approximately
w0.2–0.3. Current traces were low-pass filtered at 1 kHz
during the recording and were sampled at 500 Hz. Com-
mand potential and data acquisition were controlled by
pClamp 10.2 software (Axon Instruments). After reaching
the steady state of CFTR single-channel currents, the data
of all experiments were obtained and analyzed. The traces
were further filtered with a 100-Hz cutoff frequency for
data analysis and presentation. Reversal potential (Erev)
and slope conductance data were determined from linear
I-V plots by linear regression analysis. Bicarbonate
2020 WNK1, CFTR HCO3
 Permeability, and Pancreatitis 101permeability ratios were calculated from Erev values using
the Goldman-Hodgkin-Katz equation.
All experiments were performed at room temperature
(20–23C).
Computational Prediction of hCFTR-WNK1
Complexes
Homology Modeling of Phosphorylated, ATP-Bound
Structure of Human CFTR. Pairwise sequence align-
ment of human CFTR (hCFTR) and zebrafish CFTR was
performed using Clustal Omega (https://www.ebi.ac.uk/
Tools/msa/clustalo/). Homology models for hCFTR in the
phosphorylated, ATP-bound state were generated using
MODELLER48 based on the resolved structure of zebrafish
homolog (PDB: 5W81).35 A set of 100 homology models of
hCFTR (composed of the segments M1–G404, T438–S642,
W846–P888, T910–G1173, and D1202–K1457) were con-
structed; and the conformer with the best score (based on
MODELLER objective function) was selected for subsequent
protein-protein docking analyses.
Modeling of hCFTR-WNK1 Complex Structure. We
modeled in silico the hCFTR-WNK1 protein complex using
ClusPro.49 The cryo-EM structure of dephosphorylated
hCFTR (PDB ID: 5UAK) as well as the homology-modeled
phosphorylated conformer were used as receptors; for the
ligand, we employed WNK1 monomers deposited in the PDB
(PDB ID: 5DRB).36 Only the resolved protein structures from
hCFTR and WNK1 were used, and the bound chlorides or
inhibitors were not included in the docking analysis. For
each simulation performed with a different WNK1 mono-
mer, up to 30 hCFTR-WNK1 models were predicted by
ClusPro. These were rank-ordered based on the docking
score from ClusPro, together with 3 criteria specific to the
hCFTR-WNK1 complex in a lipid environment: (1) WNK1
should bind from the intracellular region [ie, extracellular-
bound forms were excluded]; (2) the hCFTR-WNK1
complex should have proper orientation of the aromatic
residues (ie, Trp) on the extracellular and intracellular sides
to enable suitable anchoring into the lipids; and (3) the b-
sheet portion of WNK1 should not be buried in the mem-
brane. Figure 17 displays the best conformer that meets
those criteria, stabilized by molecular dynamics (MD) sim-
ulations (see below). The hCFTR regions near R74-R75
showed a strong affinity to bind WNK1. Notably, both
phosphorylated and dephosphorylated hCFTR conformers
showed similar binding pose onto WNK1 near R74-R75. We
selected the phosphorylated hCFTR-WNK1 complex for
further refinement with MD simulations.
Refinement of the hCFTR-WNK1 Complex Structure in
the Lipid Environment With MD Simulations. The
simulation systems were prepared using CHARMM-GUI
Membrane Builder.50 The transmembrane portion of the
hCFTR-WNK1 complex was inserted into the center of a
DDPC lipid bilayer, avoiding the insertion of WNK1 into the
lipids. Fully equilibrated TIP3 waters were added to form a
rectangular box of 133  133  182 Å3. The simulation
system consisted of hCFTR, the WNK1 kinase domain, 500DDPC molecules, and about 74,000 water molecules sum-
ming up to a total of w293,000 atoms. Simulations were
performed using NAMD (version 2.9)51 and CHARMM36
force field with CMAP corrections.52,53 The simulation pro-
tocol followed our previous approach.54 The initial MD
system was first energy-minimized for 50,000 steps, fol-
lowed by 0.5 ns constant volume and temperature (T ¼
310K) simulations and a subsequent 4-ns Nosé-constant
pressure and temperature (1 bar, 310 K) simulation, during
which the protein was fixed and constraints on the DDPC
head groups were gradually released. Subsequently, the
constraints on the protein backbone were reduced from 10
kcal/mol to none within 3 ns. Finally, the unconstrained
protein was subjected to NPT simulations for 100 ns. Two
independent runs were performed. In both cases, the root-
mean-square deviation of Ca atoms from the original
structure converged to 5.0 ± 0.3 Å after 50 ns, indicating the
formation of stable complex in the presence of the lipid
bilayer. Figure 17 illustrates the simulation system equili-
brated after a 100 ns run.
Statistical Analysis
The results of multiple experiments are presented as the
mean ± SEM. Statistical analysis was performed with Stu-
dent’s t test or by analysis of variance followed by Tukey’s
multiple comparison test, as appropriate. We considered P
< .05 to be statistically significant.References
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